Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Connect Biopharma Holdings Ltd ADR (CNTB)

Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 150,382
  • Shares Outstanding, K 55,904
  • Annual Sales, $ 26,030 K
  • Annual Income, $ -15,630 K
  • EBIT $ -56 M
  • EBITDA $ -56 M
  • 60-Month Beta -0.19
  • Price/Sales 5.86
  • Price/Cash Flow N/A
  • Price/Book 2.76

Options Overview Details

View History
  • Implied Volatility 126.63% (+69.42%)
  • Historical Volatility 114.44%
  • IV Percentile 15%
  • IV Rank 6.48%
  • IV High 1,428.10% on 09/09/25
  • IV Low 36.48% on 06/17/25
  • Expected Move (DTE 20) 0.00 (0.00%)
  • Put/Call Vol Ratio 2.13
  • Today's Volume 25
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 1,547
  • Open Int (30-Day) 1,592
  • Expected Range 2.69 to 2.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.30
  • Number of Estimates 3
  • High Estimate -0.28
  • Low Estimate -0.32
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.03 +32.51%
on 12/17/25
2.89 -6.92%
on 12/26/25
-0.14 (-4.95%)
since 11/26/25
3-Month
1.23 +118.70%
on 09/30/25
3.28 -17.99%
on 11/21/25
+1.11 (+70.25%)
since 09/26/25
52-Week
0.51 +427.45%
on 04/04/25
3.28 -17.99%
on 11/21/25
+1.72 (+177.32%)
since 12/26/24

Most Recent Stories

More News
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / November 14, 2025 / RedChip Companies will air interviews with Connect Biopharma Holdings Limited (Nasdaq:CNTB) and Bimergen Energy Corp. (OCTQB:BESS) on the RedChip Small...

CNTB : 2.69 (-1.47%)
BESS : 10.6000 (-3.02%)
Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3

ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, Connect or the Company),...

CNTB : 2.69 (-1.47%)
Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FLORIDA / ACCESS Newswire / April 11, 2025 / RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited (Nasdaq:CNTB) and on the...

BFRG : 0.9520 (-5.74%)
CNTB : 2.69 (-1.47%)
Stocks Set To Open Lower As Investors Await Fed Meeting, Banking Sector Remains In Focus

June S&P 500 futures (ESM23) are down -0.13%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.10% this morning after three major U.S. benchmark indices closed in the red on Friday as ongoing concerns...

MARA : 9.59 (-3.52%)
CS : 0.8858 (+0.99%)
ESM23 : 4,453.35s (+0.61%)
HUT : 49.64 (-5.98%)
FRC : 3.51 (-43.30%)
CNTB : 2.69 (-1.47%)
UBS : 47.27 (+0.13%)
PLD : 128.71 (-0.34%)
NQM23 : 15,316.61s (+0.85%)
RIOT : 13.44 (-3.45%)
Connect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient Symptoms

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases,...

CNTB : 2.69 (-1.47%)
Connect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body Regions

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases,...

CNTB : 2.69 (-1.47%)
Connect Biopharma CBP-201 Atopic Dermatitis Abstracts from Two Trials Accepted for Presentation at the American Academy of Dermatology (AAD) Annual Meeting

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases,...

CNTB : 2.69 (-1.47%)
Connect Moves Forward CBP-201 Top-Line Results Timeline for Pivotal China Atopic Dermatitis Trial to Second Half 2022

— Connect to Evaluate Efficacy and Safety Data on 255 Patients Already Enrolled — — Expected Timing for Potential NDA Approval in China Remains...

CNTB : 2.69 (-1.47%)
Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement

SAN DIEGO, CA and TAICANG, SUZHOU, China, June 17, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the...

CNTB : 2.69 (-1.47%)
Connect Biopharma to Participate at the Jefferies Healthcare Conference

SAN DIEGO, CA and TAICANG, SUZHOU, China, June 02, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the...

CNTB : 2.69 (-1.47%)

Business Summary

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients living with chronic inflammatory diseases through the development of therapies derived from our T cell-driven research. The company's product candidate includes CBP-201. Connect...

See More

Key Turning Points

3rd Resistance Point 3.08
2nd Resistance Point 2.98
1st Resistance Point 2.84
Last Price 2.69
1st Support Level 2.60
2nd Support Level 2.50
3rd Support Level 2.36

See More

52-Week High 3.28
Last Price 2.69
Fibonacci 61.8% 2.22
Fibonacci 50% 1.89
Fibonacci 38.2% 1.57
52-Week Low 0.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar